Cargando…

Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma

Detalles Bibliográficos
Autores principales:	Silva, Arnaldo N S, Saito, Yuichi, Yoshikawa, Takaki, Oshima, Takashi, Hayden, Jeremy D, Oosting, Jan, Earle, Sophie, Hewitt, Lindsay C, Slaney, Hayley L, Wright, Alex, Inam, Imran, Langley, Ruth E, Allum, William H, Nankivell, Matthew G, Hutchins, Gordon, Cunningham, David, Grabsch, Heike I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364771/ https://www.ncbi.nlm.nih.gov/pubmed/35554502 http://dx.doi.org/10.1093/bjs/znac160

Ejemplares similares

Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
por: Silva, Arnaldo N. S., et al.
Publicado: (2022)

KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study
por: Hewitt, Lindsay C., et al.
Publicado: (2019)

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study
por: Hewitt, L.C., et al.
Publicado: (2018)

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial
por: Davarzani, Nasser, et al.
Publicado: (2018)

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
por: Hale, Matthew D., et al.
Publicado: (2016)

Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination
por: Sundar, Raghav, et al.
Publicado: (2021)

Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 Trial
por: Kloft, Maximilian, et al.
Publicado: (2023)

Identification of a high‐risk subtype of intestinal‐type Japanese gastric cancer by quantitative measurement of the luminal tumor proportion
por: Aoyama, Toru, et al.
Publicado: (2018)

Hypothesis‐free deep survival learning applied to the tumour microenvironment in gastric cancer
por: Meier, Armin, et al.
Publicado: (2020)

Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides
por: Beuque, Manon, et al.
Publicado: (2023)

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
por: Obulkasim, Askar, et al.
Publicado: (2016)

Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials
por: Athauda, Avani, et al.
Publicado: (2023)

High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers
por: Buffart, Tineke E., et al.
Publicado: (2009)

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
por: Smyth, Elizabeth C., et al.
Publicado: (2016)

Comment on: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
por: Liu, Kai, et al.
Publicado: (2022)

Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction
por: Allum, W. H., et al.
Publicado: (2019)

Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study
por: Muti, Hannah Sophie, et al.
Publicado: (2021)

Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial
por: Oshima, Takashi, et al.
Publicado: (2022)

Copy number evolution with weighted aberrations in cancer
por: Zeira, Ron, et al.
Publicado: (2020)

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
por: Alderson, Derek, et al.
Publicado: (2017)

Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning
por: Saldanha, Oliver Lester, et al.
Publicado: (2022)

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
por: Lv, Junqiang, et al.
Publicado: (2022)

Breast tumor copy number aberration phenotypes and genomic instability
por: Fridlyand, Jane, et al.
Publicado: (2006)

Conditional random pattern model for copy number aberration detection
por: Li, Fuhai, et al.
Publicado: (2010)

Network modeling of the transcriptional effects of copy number aberrations in glioblastoma
por: Jörnsten, Rebecka, et al.
Publicado: (2011)

Reduced rate of copy number aberrations in mucinous colorectal carcinoma
por: Hugen, Niek, et al.
Publicado: (2015)

CNVScope: Visually Exploring Copy Number Aberrations in Cancer Genomes
por: Dalgleish, James LT, et al.
Publicado: (2019)

Signatures of Discriminative Copy Number Aberrations in 31 Cancer Subtypes
por: Gao, Bo, et al.
Publicado: (2021)

Detecting independent and recurrent copy number aberrations using interval graphs
por: Wu, Hsin-Ta, et al.
Publicado: (2014)

FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations
por: Krijgsman, Oscar, et al.
Publicado: (2014)

Aberrant telomere length and mitochondrial DNA copy number in suicide completers
por: Otsuka, Ikuo, et al.
Publicado: (2017)

Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study
por: Veldhuizen, Gregory Patrick, et al.
Publicado: (2023)

Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial
por: Smyth, Elizabeth C., et al.
Publicado: (2019)

Improved Statistical Analysis for Array CGH-Based DNA Copy Number Aberrations
por: Jiang, Hongmei, et al.
Publicado: (2011)

Identification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian context
por: Ivyna Bong, Pau Ni, et al.
Publicado: (2014)

Identification of Copy Number Aberrations in Breast Cancer Subtypes Using Persistence Topology
por: Arsuaga, Javier, et al.
Publicado: (2015)

DNA Copy Number Aberrations in Breast Cancer by Array Comparative Genomic Hybridization
por: Li, Jian, et al.
Publicado: (2009)

Comparable Genomic Copy Number Aberrations Differ across Astrocytoma Malignancy Grades
por: Pećina-Šlaus, Nives, et al.
Publicado: (2019)

Predicting Stage-Specific Recurrent Aberrations From Somatic Copy Number Dataset
por: Aouiche, Chaima, et al.
Publicado: (2020)

Copy number aberrations drive kinase rewiring, leading to genetic vulnerabilities in cancer
por: Memon, Danish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5i173lb00ucq65h5djikn4atqi